Doxazosin mesylate and Lucentis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Doxazosin mesylate (doxazosin mesylate) and Lucentis (ranibizumab). Common drug interactions include cerebrovascular accident among females and eye pain among males.

The phase IV clinical study analyzes what interactions people have when they take Doxazosin mesylate and Lucentis. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Doxazosin mesylate?

Doxazosin mesylate has active ingredients of doxazosin mesylate. It is often used in high blood pressure. eHealthMe is studying from 11,975 Doxazosin mesylate users. Check the latest studies of Doxazosin mesylate.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

On Jul, 12, 2026

20 people who take Doxazosin mesylate and Lucentis together, and have interactions are studied.

Doxazosin mesylate and Lucentis drug interactions.

What are the common drug interactions of Doxazosin Mesylate and Lucentis, by gender? *:

female:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Lymphoma (cancer that begins in immune system cells)
Pneumonia
Pulmonary haemorrhage (acute bleeding from the lung)
Blood pressure decreased
Inappropriate antidiuretic hormone secretion
Syncope (loss of consciousness with an inability to maintain postural tone)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Loss of consciousness

male:

Eye pain
Vision blurred
Disease progression
Dyspnoea (difficult or laboured respiration)
Eye swelling
Foreign body sensation in eyes (feeling of something in eye)
Glaucoma (increased fluid pressure in the eye with vision loss)
Haemoglobin decreased
Hip fracture
Hypoglycaemia (deficiency of glucose in the bloodstream)

What are the common drug interactions of Doxazosin Mesylate and Lucentis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Pneumonia
Inappropriate antidiuretic hormone secretion
Syncope (loss of consciousness with an inability to maintain postural tone)
Vitreous haemorrhage (intraocular (inside the eye) bleeding)
Abnormal sensation in eye
Asthenia (weakness)
Cardiac failure congestive
Cataract (clouding of the lens inside the eye)
Conjunctival haemorrhage (bleeding underneath the conjunctiva)

What are the existing conditions these people have? *

Age-Related Macular Degeneration: 9 people, 45.00%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 2 people, 10.00%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 1 person, 5.00%
Ocular Vascular Disorder (disease of eye blood circulation): 1 person, 5.00%
Hyperkalemia (damage to or disease of the kidney): 1 person, 5.00%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 1 person, 5.00%
Cardiac Failure: 1 person, 5.00%
Anaesthesia: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Doxazosin mesylate and Lucentis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously